The FDA is inviting drug manufacturing companies to take part in the second year of a program that evaluates and improves their quality management. This voluntary program will use a refined assessment protocol to determine how mature and effective their quality management practices are. The FDA aims to select a diverse group of up to nine companies for this program, which will include a week-long review and feedback session. Companies interested in participating need to apply by June 9, 2025.
Simple Explanation
The FDA wants to check how well some drug companies manage their quality, kind of like how a teacher checks homework. They're inviting a few companies to join a special program and get feedback on how they do things. Companies need to sign up by June 9, 2025, if they want to play this "quality check" game.